3-5 Cups of Coffee A Day Linked to Longer Life, Lower Diabetes Risk

Health & LifestyleNews
108

Listen to article (english)

Translate to Spanish or other 102 languages!

New research ties coffee drinking to many health benefits. Image for illustration purposes
New research ties coffee drinking to many health benefits. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

What health benefits does coffee offer? Does adding cream and sugar make a difference in the benefits? Is there anyone who should avoid coffee?

A review published in Nutrients discusses much of these questions and the currently available information on coffee, including how it decreases mortality risk and risk for several diseases.

- Advertisement -

It also discusses coffee’s impact on well-being, the possible mechanisms responsible for its effects, coffee additives, areas of concern, and future research.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/3-5-cups-coffee-day-linked-longer-life-lower-diabetes-risk-review?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-08-27&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f#1

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
How Many Steps Do We Really Need Each Day?
Next article
Hidalgo County Health Dept. to Unveil First OnMed CareStation Offering No-Cost Primary Care, Sept 3rd

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -